The combined use of Flu/ATG in nonmyeloablative SCT for severe aplastic anemia with multiple earlier transfusions.

Niparuck, P; Ungkanont, A; Ativitavas, T; Jootar, S

Niparuck, P; Ungkanont, A; Ativitavas, T; Jootar, S.

Bone Marrow Transplant ; 43(11): 887-9, 2009 Jun.

Article in En | MEDLINE | ID: mdl-19079311

Subject(s)

Anemia, Aplastic/therapy; Antilymphocyte Serum/administration & dosage; Hematopoietic Stem Cell Transplantation; Vidarabine/analogs & derivatives; Adult; Anemia, Aplastic/diagnosis; Combined Modality Therapy; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease/diagnosis; Graft vs Host Disease/therapy; Hematopoietic Stem Cell Transplantation/adverse effects; Humans; Male; Middle Aged; Recurrence; Treatment Outcome; Vidarabine/administration & dosage; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vidarabine / Hematopoietic Stem Cell Transplantation / Anemia, Aplastic / Antilymphocyte Serum Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Year: 2009 Document type: Article

Fulltext

XML

PubMed Links

Search on Google